Association of the CD226 Ser307 variant with systemic sclerosis

Arthritis and Rheumatism

Volumn 63, Issue 4, 2011, Pages 1097-1105

  Dieude P ^a,t   Guedj, M ^b   Truchetet, M E ^c   Wipff, J ^a   Revillod, L ^a   Riemekasten, G ^d   Matucci Cerinic, M ^e   Melchers, I ^f   Hachulla, E ^g   Airo, P ^h   Diot, E ⁱ   Hunzelmann, N ^j   Mouthon, L ^a   Cabane, J ^k   Cracowski, J L ^l   Riccieri, V ^m   Distler, J ⁿ   Amoura, Z ^o   Valentini, G ^p   Camaraschi, P ^q   Tarner, I ^r   Frances, C ^o   Carpentier, P ^l   Brembilla, N C ^c   Meyer, O ^a   Kahan, A ^a   Chizzolini, C ^c   Boileau, C ^a,s   Allanore, Y ^a   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIV LILLE   (France)

^h SPEDALI CIVILI   (Italy)

ⁱ CHU BRETONNEAU   (France)

^j UNIVERSITY OF COLOGNE   (Germany)

^k HÔPITAL SAINT ANTOINE   (France)

^l GRENOBLE UNIVERSITY HOSPITAL   (France)

^m SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁿ UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^o SORBONNE UNIVERSITÉ   (France)

^p SECOND UNIVERSITY OF NAPLES   (Italy)

^q UNIVERSITY OF VERONA   (Italy)

^r JUSTUS LIEBIG UNIVERSITY   (Germany)

^s LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^t BICHAT HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD226 ANTIGEN; DNA TOPOISOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; EUROPEAN AMERICAN; FEMALE; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES;

EID: 79953687390     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30204     Document Type: Article

References (27)

1. Allanore Y, Wipff J, Kahan A, Boileau C. Genetic basis for systemic sclerosis. Joint Bone Spine 2007;74:577-83. (Pubitemid 350245624)
2. Chizzolini C. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis. Curr Opin Rheumatol 2008;20:707-12.
3. Allanore Y, Dieude P, Boileau C. Genetic background of systemic sclerosis: autoimmune genes take centre stage. Rheumatology (Oxford) 2010;49:203-10.
4. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39:857-64. (Pubitemid 47018195)
5. Hafler JP, Maier LM, Cooper JD, Plagnol V, Hinks A, Simmonds MJ, et al. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 2009;10:5-10.
6. Wieczorek S, Hoffjan S, Chan A, Rey L, Harper L, Fricke H, et al. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes Immun 2009;10:591-5.
7. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996;4:573-81. (Pubitemid 26233311)
8. Tao D, Shangwu L, Qun W, Yan L, Wei J, Junyan L, et al. CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. J Immunol 2005;174:1281-90.
9. Chizzolini C. Update on pathophysiology of scleroderma with special reference to immunoinflammatory events. Ann Med 2007; 39:42-53. (Pubitemid 46277058)
10. Horikawa M, Hasegawa M, Komura K, Hayakawa I, Yanaba K, Matsushita T, et al. Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity. J Invest Dermatol 2005;125:731-7.
11. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001;413:531-4. (Pubitemid 32938752)
12. Dieude P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E, et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 2009;60:225-33.
13. Dieude P, Guedj M, Wipff J, Avouac J, Hachulla E, Diot E, et al. The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum 2008;58:2183-8. (Pubitemid 351988112)
14. Dieude P, Guedj M, Wipff J, Ruiz B, Hachulla E, Diot E, et al. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum 2009;60:2472-9.
15. Dieude P, Wipff J, Guedj M, Ruiz B, Melchers I, Hachulla E, et al. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum 2009;60:3447-3454.
16. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
17. Valentini G, Matucci-Cerinic M. Disease-specific quality ndicators, guidelines and outcome measures in scleroderma. Clin Exp Rheumatol 2007;25 Suppl 47:159-62.
18. Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 2008;47:1185-92. (Pubitemid 352038224)
19. Dieude P, Dawidowicz K, Guedj M, Legrain Y, Wipff J, Hachulla E, et al. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. J Rheumatol 2010;37:987-92.
20. Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- α/β T cells demonstrates preferential use of several Vβgenes and an invariant TCR α chain. J Exp Med 1993;178:1-16. (Pubitemid 23173239)
21. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010;42:426-9.
22. Dardalhon V, Schubart AS, Reddy J, Meyers JH, Monney L, Sabatos CA, et al. CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J Immunol 2005;175:1558-65. (Pubitemid 41023057)
23. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4. (Pubitemid 46999798)
24. Shibuya K, Lanier LL, Phillips JH, Ochs HD, Shimizu K, Nakayama E, et al. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 1999;11:615-23.
25. Shirakawa J, Shibuya K, Shibuya A. Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226). Int Immunol 2005;17:217-23. (Pubitemid 40372644)
26. Lofgren SE, Delgado-Vega AM, Gallant CJ, Sanchez E, Frostegard J, Truedsson L, et al. A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum 2010;62:3404-14.
27. Gourh P, Arnett FC, Tan FK, Assassi S, Divecha D, Paz G, et al. Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis. Ann Rheum Dis 2010;69:550-5.